Skip to main content

Dysport

NDC 0299-5962 · Galderma Laboratories, L.P.

Generic nameBotulinum Toxin Type A
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAMUSCULAR
Active ingredient(s)BOTULINUM TOXIN TYPE A
Strength300 U/1
Pharmacologic classAcetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]
Marketing categoryBLA

Packages

0299-5962-01 — 1 VIAL in 1 CARTON (0299-5962-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

0299-5962-30 — 1 VIAL in 1 CARTON (0299-5962-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Billed under HCPCS

J0586 — Injection, abobotulinumtoxina, 5 units Medicare Part B payment limit (ASP + 6%): $8.94

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0023-1145 — onabotulinumtoxinA, 0023-3919 — onabotulinumtoxinA, 0023-3921 — onabotulinumtoxinA, 0023-9232 — onabotulinumtoxinA, 0259-1605 — incobotulinumtoxinA, 0259-1610 — incobotulinumtoxinA, 0259-1620 — incobotulinumtoxinA, 0259-4110 — incobotulinumtoxinA, 0259-4150 — incobotulinumtoxinA, 15054-0500 — Botulinum Toxin Type A, 15054-0530 — Botulinum Toxin Type A, 46783-160 — incobotulinumtoxinA, 46783-161 — incobotulinumtoxinA, 46783-165 — incobotulinumtoxinA, 72301-595 — Prabotulinum Toxin Type A, 72960-112 — botulinum toxin type A, 85766-155 — onabotulinumtoxinA

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources